Literature DB >> 3830249

Verapamil and norverapamil in plasma and breast milk during breast feeding.

P Anderson, U Bondesson, I Mattiasson, B W Johansson.   

Abstract

The concentrations of verapamil and norverapamil have been measured in milk and plasma samples from a 32 year-old woman treated with verapamil 80 mg tds while breast-feeding her child. The average steady-state concentrations of verapamil and noverapamil in milk were, respectively, 60% and 16% of the concentrations in plasma. The breast-fed child received less than 0.01% of the dose of verapamil given to the mother. No verapamil or norverapamil (less than 1 ng/ml) could be detected in the plasma from the child.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3830249     DOI: 10.1007/bf00606644

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  Level of verapamil in human milk.

Authors:  H Inoue; N Unno; M C Ou; Y Iwama; T Sugimoto
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

2.  Excretion of verapamil in human milk.

Authors:  M de Swiet
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-25

3.  Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D,L-verapamil using stable isotope-labelled verapamil.

Authors:  M Eichelbaum; A Somogyi; G E von Unruh; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

4.  Physiological disposition of verapamil in man.

Authors:  M Schomerus; B Spiegelhalder; B Stieren; M Eichelbaum
Journal:  Cardiovasc Res       Date:  1976-09       Impact factor: 10.787

5.  The pharmacology of verapamil. IV. Kinetic and dynamic effects after single intravenous and oral doses.

Authors:  R G McAllister; E B Kirsten
Journal:  Clin Pharmacol Ther       Date:  1982-04       Impact factor: 6.875

6.  Reduced verapamil clearance during long-term oral administration.

Authors:  D G Shand; S C Hammill; L Aanonsen; E L Pritchett
Journal:  Clin Pharmacol Ther       Date:  1981-11       Impact factor: 6.875

7.  Verapamil and breast-feeding.

Authors:  M R Miller; R Withers; R Bhamra; D W Holt
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Clinical pharmacokinetics of verapamil in patients with atrial fibrillation.

Authors:  P Anderson; U BondessoN; C Sylvén
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

9.  Superiority of stable isotope techniques in the assessment of the bioavailability of drugs undergoing extensive first pass elimination. Studies of the relative bioavailability of verapamil tablets.

Authors:  M Eichelbaum; H J Dengler; A Somogyi; G E von Unruh
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

10.  Verapamil disposition kinetics in chronic atrial fibrillation.

Authors:  R E Kates; D L Keefe; J Schwartz; S Harapat; E B Kirsten; D C Harrison
Journal:  Clin Pharmacol Ther       Date:  1981-07       Impact factor: 6.875

View more
  7 in total

1.  Prediction of drug distribution into human milk from physicochemical characteristics.

Authors:  H C Atkinson; E J Begg
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

2.  Excretion of tiapamil in breast milk.

Authors:  D Hartmann; N O Lunell; G Friedrich; A Rane
Journal:  Br J Clin Pharmacol       Date:  1988-08       Impact factor: 4.335

Review 3.  Cluster Headache: Special Considerations for Treatment of Female Patients of Reproductive Age and Pediatric Patients.

Authors:  Juliana VanderPluym
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

Review 4.  Poisoning due to calcium antagonists. Experience with verapamil, diltiazem and nifedipine.

Authors:  P D Pearigen; N L Benowitz
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

Review 5.  Breastfeeding and migraine drugs.

Authors:  Riccardo Davanzo; Jenny Bua; Giulia Paloni; Giulia Facchina
Journal:  Eur J Clin Pharmacol       Date:  2014-09-13       Impact factor: 2.953

Review 6.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 7.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.